Patents by Inventor John M. Werzel

John M. Werzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
    Patent number: 8198313
    Abstract: This invention is directed to indolone derivatives which are antagonists for the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: June 12, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman
  • USE OF GALR3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF DEPRESSION AND/OR ANXIETY AND COMPOUNDS USEFUL IN SUCH METHODS
    Publication number: 20110178125
    Abstract: This invention is directed to indolone derivatives which are antagonists for the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 10, 2011
    Publication date: July 21, 2011
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman
  • Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
    Patent number: 7868034
    Abstract: This invention is directed to indolone derivatives which are antagonists or the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 17, 2008
    Date of Patent: January 11, 2011
    Assignee: H. Lundbeck A/S
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman
  • USE OF GALR3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF DEPRESSION AND/OR ANXIETY AND COMPOUNDS USEFUL IN SUCH METHODS
    Publication number: 20090176840
    Abstract: This invention is directed to indolone derivatives which are antagonists or the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 17, 2008
    Publication date: July 9, 2009
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman
  • Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
    Patent number: 7081470
    Abstract: This invention is directed to indolone derivatives which are antagonists for the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: July 25, 2006
    Assignee: H. Lundbeck A/S
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman
  • Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
    Publication number: 20040102507
    Abstract: This invention is directed to indolone derivatives which are antagonists for the GALR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 16, 2003
    Publication date: May 27, 2004
    Inventors: Michael Konkel, John M. Werzel, Jamie Talisman